Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,830
Closed -$290K 1063
2026
Q1
$290K Sell
3,830
-604
-14% -$45.4K ﹤0.01% 700
2025
Q4
$330K Sell
4,434
-520
-10% -$38K ﹤0.01% 638
2025
Q3
$334K Buy
4,954
+4
+0.1% +$266 ﹤0.01% 619
2025
Q2
$323K Buy
+4,950
New +$297K 0.01% 557
2025
Q1
Sell
-3,459
Closed -$249K 629
2024
Q4
$249K Buy
+3,459
New +$270K ﹤0.01% 505
2020
Q3
Sell
-316
Closed -$18K 533
2020
Q2
$18K Buy
316
+278
+732% +$13.6K ﹤0.01% 643
2020
Q1
$1K Buy
+38
New +$1.81K ﹤0.01% 1077
2017
Q2
Sell
-69
Closed -$3K 565
2017
Q1
$3K Sell
69
-71
-51% -$2.9K ﹤0.01% 553
2016
Q4
$6K Hold
140
﹤0.01% 504
2016
Q3
$5K Sell
140
-13
-8% -$491 ﹤0.01% 538
2016
Q2
$5K Buy
153
+98
+178% +$3.39K ﹤0.01% 545
2016
Q1
$2K Hold
55
﹤0.01% 583
2015
Q4
$2K Buy
+55
New +$2.14K ﹤0.01% 656

Other funds holding HOLX

Citizens Financial Group's HOLX Position: Q2 2026 in Review

Citizens Financial Group sold out of Hologic (HOLX) in Q2 2026, closing a stake of 3,830 shares — an estimated $290K sold.

Citizens Financial Group first reported a position in HOLX in Q4 2015 and held it in 13 quarters. The position peaked at $334K in Q3 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Citizens Financial Group reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Citizens Financial Group sold 3,830 Hologic shares in Q2 2026, an estimated $290K.
  • Citizens Financial Group first reported a position in Hologic in Q4 2015 and held it in 13 quarters.
  • Citizens Financial Group's Hologic position peaked at $334K in Q3 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Citizens Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.